Epidermolytic hyperkeratosis (EHK)
Overview
Epidermolytic hyperkeratosis (EHK), now more commonly called epidermolytic ichthyosis, is a rare, genetic skin disorder characterized by severe blistering at birth and thick, scaly skin development later in life.
Symptoms
• Widespread redness (erythroderma): Skin appears bright red or raw at birth.
• Blisters and peeling: Fragile skin easily forms fluid-filled blisters (bullae) and peels away (denuded skin) with minor friction or touch.
• Systemic risks: Missing skin barriers can lead to dangerous dehydration, electrolyte imbalances, and severe skin or systemic infections (sepsis).
• Thickened skin (hyperkeratosis): Blistering decreases over time, and the skin forms thick, dark-brown, gray, or yellowish-white scales or verrucous (wart-like) plaques.
• Flexural involvement: Thickening is often most prominent over skin creases and joints (such as the elbows, knees, neck, wrists, and ankles).
• Painful fissuring and erosions: The hardened skin cracks easily, causing deep, painful fissures and secondary erosions.
• Palm and sole patterns: Depending on the specific genetic mutation (such as keratin 1 vs. keratin 10), individuals may develop thick calluses on the palms of the hands and soles of the feet (palmoplantar keratoderma), or have relatively spared palms and soles.
• Distinct odor: Bacteria can easily colonize the thick, scaly skin folds, producing a characteristic pungent body odor.
• Anhidrosis (decreased sweating): Thick skin layers can clog sweat glands, making it difficult for the body to cool itself properly.
• Pruritus (itching): Chronic, intense itching often leads to scratching, further damaging the fragile skin.
• Other complications: Scale buildup can cause hearing issues if it accumulates in the ear canals, or thin hair if it blocks scalp follicles.
Causes
• Gene Instructions: The KRT1 and KRT10 genes provide instructions to make keratin 1 and keratin 10 proteins. These proteins form tough, fibrous networks (intermediate filaments) inside skin cells called keratinocytes, giving the outer layer of skin (epidermis) strength and flexibility.
• Defective Filaments: Mutations (usually missense/point mutations) alter these keratin proteins, stopping them from forming stable filament networks. Without structural stability, keratinocytes become fragile and easily damaged by minor friction or pressure, causing blisters and peeling
• KRT1 mutations often affect both the body and the palms of the hands and soles of the feet (palmoplantar keratoderma).
• KRT10 mutations generally do not affect the palms and soles because keratin 10 is not normally expressed there.
• A rare variant limited strictly to the palms and soles involves mutations in the KRT9 gene
• Autosomal Dominant: Most cases are inherited in an autosomal dominant pattern, meaning a child only needs one copy of the mutated gene from an affected parent to develop the condition.
• Spontaneous (De Novo) Mutations: About 50% of cases occur due to a brand-new (spontaneous) genetic mutation at conception or during early embryonic development, with no family history.
• Genetic Mosaicism: Some parents with a localized skin lesion (epidermal nevus) carrying the mutation can pass generalized epidermolytic ichthyosis to their children if the mutation affects their germline cells (gonadal mosaicism).
• Autosomal Recessive: Rare recessive forms linked to loss-of-function KRT10 mutations have also been documented in specific families
Diagnosis
• Infants: Often present at birth or shortly after with generalized redness (erythroderma), blistering (bullae), and fragile skin that can mimic a severe burn or infection.
• Children and Adults: Blisters decrease over time, and the skin evolves into thick, wart-like (verrucous), scaly plaques, often with a "corrugated cardboard" pattern on palms or a "cobblestone" pattern on flexural and extensor skin folds
2. Histopathology (Skin Biopsy)
• A skin biopsy is frequently performed for microscopic evaluation, showing classic and highly characteristic features:
• Marked thickening of the outer skin layer (hyperkeratosis).
• Degeneration and vacuolization (clear spaces/blistering) in the upper layers of the epidermis (suprabasal cytolysis).
• Coarse, irregular clumps of keratin intermediate filaments and abnormal keratohyaline granules.
3. Molecular Genetic Testing
• Considered the definitive or gold-standard method to confirm the diagnosis.
• Uses blood samples or buccal (cheek) swabs to test for heterozygous mutations in the KRT1 or KRT10 keratin genes.
• Can also be utilized for family screening or prenatal diagnosis via chorionic villus sampling or amniocentesis.
Treatment
• Hydration and Moisturization: Regular, frequent bathing followed immediately by thick emollients, lipid agents (like petrolatum or glycerol), and products containing urea, lactic acid, propylene glycol, or alpha-hydroxy acids helps soften and shed thick scales.
• Keratolytics: Topical agents like salicylic acid, urea, or alpha-hydroxy acids are used to help break down and reduce excess keratin scaling. (Note: High-concentration salicylic acid should be avoided over large areas to prevent toxicity).
• Infection Control & Antiseptics: Because cracked skin is prone to bacterial colonization, antiseptic washes (such as chlorhexidine) or dilute sodium hypochlorite (bleach) baths help reduce infection risks. Overt bacterial infections require topical or systemic antibiotics.
• Retinoids: Oral retinoids (such as acitretin or isotretinoin) or topical retinoids may be prescribed in severe cases to reduce hyperkeratinization, though they must be monitored closely because they can increase skin fragility and blistering.
Targeted and Biologic Therapies: Emerging treatments—such as IL-4 receptor antagonists (like dupilumab) or IL-17A inhibitors (like secukinumab or vunakizumab)—have shown success in individual or trial cases for reducing inflammation, itching, and redness.
Type of Doctor Department : A dermatologist
.jpg)
Comments
Post a Comment